Intestinal flora regulates tumor microenvironment components

Intestinal flora regulates tumor microenvironment components. TAMs: Helicobacter hepaticus can activate TAMs and inhibit the production of IL-10, thus inhibiting the development of breast cancer. The imbalance of gut microbiota directly activates macrophages, macrophages release IL-6, TNF-α and CXCL10. IL-6 and TNF-α accelerate the development of CRC by promoting EMT, while CXCL10 induces T-cell infiltration in the tumor microenvironment and promotes the development of HCC. Intestinal microbiota bacterial diseases induce tumor cells to secrete CTSK, thereby activating macrophages through mTOR-dependent pathways. CTSK stimulates the macrophage secretion of IL-10 and IL-17, thus promoting the invasion and metastasis of CRC cells. Some symbiotic microbiota stimulate macrophages to increase c-Jun phosphorylation in CRC cells through the JNK signaling pathway, thus accelerating CRC cell proliferation. Intestinal microbiota bacterial diseases also induce the production of IL-25 from cluster cells, which promotes EMT and the migration of HCC cells. CAFs: CAFs influence the tumor immune microenvironment by recruiting chemokines and immune factors. MDSCs: IL-17 recruits bone MDSCs into the colon tumor microenvironment of mice colonized with enterotoxin bacteria, which indirectly induce the ectopic production of chemokines and growth factors through direct interaction with IL-17 receptors in CECs, and the expression of IL-17 in submucosa. IL-17 and transformed CECs jointly promote tumor development with angiogenic mediators, namely MMP-9 and VEGF, by inhibiting immune effector cells and activating the STAT3 signaling pathway. Early lack of microbiota in mice enhances the expression of C-X-C motif receptor 2 ligands. A number of gut pathogenic microorganisms or gut microbiota and their synergistic interactions with cytokines activate and proliferate MDSCs in the tumor microenvironment, thus mediating the immune escape of tumor cells. TANs: Helicobacter hepaticus can induce the generation of neutrophils, thereby inducing nitric oxide and TNF-α increased content, which activates the NF-κB signaling pathway and promotes tumor generation. DCs: Lipopolysaccharide and TNF-α stimulate DCs to mature and activate, and subsequently activate T cells to produce IL-2 to form an antitumor microenvironment. TAMs, tumor-associated macrophages; CRC, colorectal cancer; EMT, epithelial-mesenchymal transition; HCC, hepatocellular carcinoma; CTSK, carnosine K; CAFs, cancer-associated fibroblasts; MDSCs, myeloid-derived suppressor cells; CECs, colon epithelial cells; DCs, dendritic cells; TANs, tumor-associated neutrophils; CXCL, C-X-C motif ligand
Intestinal flora regulates tumor microenvironment components

Publication

Advances in the role of gut microbiota in the regulation of the tumor microenvironment (Review) (2023) Tian Xinyuan, et al. Oncol Rep. 2023 Oct;50(4). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates access ACCES ncbigene_synonym UBA2 10054
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates cwc2 CWC2 ncbigene_synonym RBM22 55696
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates LPS LPS ncbigene_synonym IRF6 3664
Homo sapiens Primates TLR4 TLR4 ncbigene_symbol TLR4 7099
Homo sapiens Primates TIL TIL ncbigene_synonym TLR1 7096
Homo sapiens Primates VEGF VEGF ncbigene_synonym VEGFA 7422
Homo sapiens Primates VEGF VEGF famplex_relations VEGFB 7423
Homo sapiens Primates VEGF VEGF famplex_relations VEGFC 7424
Homo sapiens Primates VEGF VEGF famplex_relations VEGFD 2277
Homo sapiens Primates VEGF VEGF famplex_relations PGF 5228
Homo sapiens Primates TNF-α TNF ncbigene_symbol TNF 7124
Homo sapiens Primates CTSK CTSK ncbigene_symbol CTSK 1513
Homo sapiens Primates HIF-1 HIF-1 ncbigene_synonym SETD2 29072

Chemical mentions

Word Match MeSH Name ChEBI
LPS LPS chebi:89981
LPS LPS chebi:89981

Disease mentions

Word Match MeSH Name DOID
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
carcinoma carcinoma carcinoma DOID:305
cancer cancer cancer DOID:162
carcinoma carcinoma carcinoma DOID:305
cancer cancer cancer DOID:162
Cancer cancer cancer DOID:162
Colorectal cancer colorectal cancer colorectal cancer DOID:9256
Breast cancer breast cancer breast cancer DOID:1612
colorectal cancer colorectal cancer colorectal cancer DOID:9256
colorectal cancer colorectal cancer colorectal cancer DOID:9256
Colorectal cancer colorectal cancer colorectal cancer DOID:9256
Hepatocellular carcinoma hepatocellular carcinoma hepatocellular carcinoma DOID:684
colorectal cancer colorectal cancer colorectal cancer DOID:9256